Faculty profile

Abhinav Sharma

ResearcherMedicine/CardiologyMcGill University

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a McGill University directory, so their courses may be missing. Find their university profile.

Abhinav Sharma

Researcher

Medicine/Cardiology

Health Sciences

McGill University

Montreal, Quebec, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
106 publications in the last five years, latest in 2026.
Senior (last) author on 27 recent papers, a sign of leading a research group.
Principal investigator on 5 research grants (5 CIHR), most recently in 2025.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

154

Publications

562

Citations

Collaborators

Grants

Publications by year

Counts cover the publications linked to this profile. Citations and the h-index appear when the source records them.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Heart Failure Gender Social Determinants Of Health Cardia Magnetic Resonnance Cardiovascular Outcomes Clinical Clustering Integrative Multi-Omics Latent Class Analysis

Latest papers

Author Correction to “Canadian Cardiovascular Society/Canadian Heart Failure Society 2025 Guideline Update for Pharmacologic Management of Heart Failure With Nonreduced Ejection Fraction (LVEF > 40%) [Canadian Journal of Cardiology, Volume 41, Issue 10, Pages 1857-1874. DOI: 10.1016/j.cjca.2025.07.027]”
Canadian Journal of Cardiology · 2026 · senior author
Author Correction to Canadian Cardiovascular Society/Canadian Heart Failure Society 2025 Guideline Update for Pharmacologic Management of Heart Failure With Nonreduced Ejection Fraction (LVEF > 40%) [Canadian Journal of Cardiology. Volume 41, Issue 10, Pages 1857-1874. DOI:10.1016/j.cjca.2025.07.027]
Canadian Journal of Cardiology · 2026
Implications of Generic Semaglutide Availability on the Cost-Effectiveness of GLP-1RA for Guideline-Indicated Patients With Type 2 Diabetes.
The Canadian journal of cardiology · 2026

All 154 publications

Latest funding

Deconstructing the phenotypic heterogeneity of type-2-diabetes associated with cardiovascular outcomes through multi-omics profiling and clinical clustering: DECIDE-CCVS program
CIHR · 2025 · Nominated PI
$703,800
Understanding Sex and Gender Differences in the Impact of Psychological Distress on Cardiovascular Disease Progression
CIHR · 2025 · Co-investigator
$504,901
The mechano-regulation of naive T cell survival: consequences for aging and autoimmunity.
CIHR · 2025 · Co-investigator
$1,189,576

All 16 grants and awards

From the 150 most recent of 154 publications.

Author Correction to “Canadian Cardiovascular Society/Canadian Heart Failure Society 2025 Guideline Update for Pharmacologic Management of Heart Failure With Nonreduced Ejection Fraction (LVEF > 40%) [Canadian Journal of Cardiology, Volume 41, Issue 10, Pages 1857-1874. DOI: 10.1016/j.cjca.2025.07.027]”

Panel: P, Virani S, Zieroth S, Aleksova N, Anderson K, Clarke B, Ducharme A, Ezekowitz JA, Foroutan F, Giannetti N

Canadian Journal of Cardiology20261 citationsSenior author

DOI: 10.1016/j.cjca.2026.03.026

Author Correction to Canadian Cardiovascular Society/Canadian Heart Failure Society 2025 Guideline Update for Pharmacologic Management of Heart Failure With Nonreduced Ejection Fraction (LVEF > 40%) [Canadian Journal of Cardiology. Volume 41, Issue 10, Pages 1857-1874. DOI:10.1016/j.cjca.2025.07.027]

Virani S, Zieroth S, Aleksova N, Anderson K, Clarke B, Ducharme A, Ezekowitz JA, Foroutan F, Giannetti N, Jain R

Canadian Journal of Cardiology2026

DOI: 10.1016/j.cjca.2025.12.030

Implications of Generic Semaglutide Availability on the Cost-Effectiveness of GLP-1RA for Guideline-Indicated Patients With Type 2 Diabetes.

McNally E, Sharma A, Marques P, Tsoukas MA, Mavrakanas TA, Russell WA

The Canadian journal of cardiology2026

DOI: 10.1016/j.cjca.2026.05.013 PMID: 42484591

Advancements in wearable technology for heart failure patients.

Perlman G, Leroux J, Sharma A

Current opinion in cardiology2026Senior author

DOI: 10.1097/hco.0000000000001326 PMID: 42388093

Renin, Aldosterone, and Treatment Response to Dapagliflozin, Spironolactone, and Their Combination: An Analysis From SOGALDI-PEF.

Ferreira JP, Marques P, Neves JS, Leite AR, Teixeira C, Saraiva F, Sharma A, Zannad F, Pimenta J, Fontes-Carvalho R, Leite-Moreira A, Vasques-Nóvoa F, SOGALDI-PEF Investigators

JACC. Heart failure2026

DOI: 10.1016/j.jchf.2026.103111 PMID: 42201301

Therapies for Cardiovascular-Kidney-Liver-Metabolic Syndrome: Reappraisal of Fibrates.

Anagnostopoulou V, Travlos CK, Marinho LL, Mavrakanas TA, Ferreira JP, Sharma A

Diabetes, obesity & metabolism2026Senior author

DOI: 10.1111/dom.71230 PMID: 42608342

Impact of dapagliflozin, spironolactone, and their combination on markers of kidney function and injury: an analysis from SOGALDI-PEF.

Ferreira JP, Mascarenhas J, Marques P, Mendonça L, Sharma A, Zannad F, Almeida JS, Fontes-Carvalho R, Pimenta J, Leite-Moreira A, Vasques-Nóvoa F, SOGALDI-PEF investigators

European journal of heart failure2026

DOI: 10.1093/ejhf/xuag117 PMID: 41965102

Innovative strategies to reduce heart failure hospitalizations: insights from the ESC heart failure congress 2026.

Haichin K, Leroux J, Giannetti N, Sharma A

Heart failure reviews2026Senior author

DOI: 10.1007/s10741-026-10662-y PMID: 42550328

Sex-Focused Evaluation of Income and Education and the Risk of Atherosclerotic Cardiovascular Diseases Within a Universal Healthcare Context.

Haichin K, Alter D, Poirier P, Ni J, Tardif JC, Goodman SG, Yan A, Ko D, d'Entremont MA, Lawler PR, Spaziano M, Sharma A, Thanassoulis G, Dery JP, Nguyen M, Mansour S, Lee DS, Schampaert E, Huynh T

CJC open2026

DOI: 10.1016/j.cjco.2026.03.014 PMID: 42610040

Mechanosensing by T cells promotes a tissue-resident memory transcriptional program.

Postat J, Merino M, Mingarelli AR, Cerf A, Bhagrath A, Patel D, Shen C, Brodbeck J, Tirgar P, Rogers D, Blanc J, Jeyakumar T, Schneider C, Coley S, Giannetti N, DePauw TA, Textor J, Ehrlicher A, Jameson SC, Sharif-Naeini R, Sharma A, Mandl JN

Nature immunology2026

DOI: 10.1038/s41590-026-02581-9 PMID: 42399696

Write to this professor

A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.

Applying for

Paper to mentionMention their CIHR grant from 2025

Subject: Prospective PhD student: Heart Failure Dear Professor Sharma, My name is [your name], and I am a [your current degree or role] at [your institution]. I am applying for a PhD position starting in [term and year]. I read your paper "Author Correction to “Canadian Cardiovascular Society/Canadian Heart Failure Society 2025 Guideline Update for Pharmacologic Management of Heart Failure With Nonreduced Ejection Fraction (LVEF > 40%) [Canadian Journal of Cardiology, Volume 41, Issue 10, Pages 1857-1874. DOI: 10.1016/j.cjca.2025.07.027]”" (2026), and it connects closely to my own work on [your research topic]. [One or two sentences on what you did and what you learned.] I also saw your CIHR-funded project "Deconstructing the phenotypic heterogeneity of type-2-diabetes associated with cardiovascular outcomes through multi-omics profiling and clinical clustering: DECIDE-CCVS program" (2025), and I would be glad to contribute to work in that direction. Are you accepting new PhD students for [term and year]? I have attached my CV and transcripts, and I would be glad to talk at a time that suits you. Thank you for your time. Kind regards, [your name]

Something wrong or missing on this profile? Suggest a correction

Abhinav Sharma

Research

Latest papers

Latest funding

Implications of Generic Semaglutide Availability on the Cost-Effectiveness of GLP-1RA for Guideline-Indicated Patients With Type 2 Diabetes.

Advancements in wearable technology for heart failure patients.

Renin, Aldosterone, and Treatment Response to Dapagliflozin, Spironolactone, and Their Combination: An Analysis From SOGALDI-PEF.

Therapies for Cardiovascular-Kidney-Liver-Metabolic Syndrome: Reappraisal of Fibrates.

Impact of dapagliflozin, spironolactone, and their combination on markers of kidney function and injury: an analysis from SOGALDI-PEF.

Innovative strategies to reduce heart failure hospitalizations: insights from the ESC heart failure congress 2026.

Sex-Focused Evaluation of Income and Education and the Risk of Atherosclerotic Cardiovascular Diseases Within a Universal Healthcare Context.

Mechanosensing by T cells promotes a tissue-resident memory transcriptional program.

Frequent collaborators

Nadia Giannetti

Subodh Verma

Robert Avram

Thao Huynh

Lisa Mielniczuk

Sabina Keen

Amelia Yip

Walter Swardfager

Douglas Lee

Harriette Van Spall

Michael Tsoukas

Alexandra King

Justin Ezekowitz

Bernard Zinman

Yasbanoo Moayedi

Morgan Craig

Morgan Craig

Laura Banks

Tricia Peters

Dennis Ko

Amal Bessissow

Jean-Claude Tardif

Jonathan Afilalo

Allen Ehrlicher

Ariane Marelli

Adeera Levin

Tomoko Takano

George Thanassoulis

Jean-Claude Tardif

Peter Senior

Guillaume Marquis-Gravel

Thomas Mavrakanas

Daniel Fuller

Jacqueline Joza